New Business Opportunities in Bio/Pharma,
Medical Devices & Diagnostics
Welcome to the March 2015 issue of PharmSource PERISCOPE
This monthly e-newsletter provides valuable insight to sales and marketing professionals who sell goods and services to bio/pharma, medical device or diagnostic companies. It helps you recognize new business opportunities and overcome sales obstacles.
Enjoy the March issue!
PharmSource Lead Sheet Global Activity Report:
|Lead Type||February 2015||2015 YTD|
|Total Drug Leads||415||905|
|Total Device &
*Total leads include acquisitions/alliances, company acquisition/alliances and events.
Phosphate Therapeutics completes recruitment in a Phase II trial with PT20 for the treatment of hyperphosphatemia in patients with pre-dialysis and dialysis-dependent chronic kidney disease. Learn more.
Pipeline Attrition: A Lead Sheet Perspective
by Saul Richmond, Director, Market Intelligence
In clinical trials, not all failures are equal. Late stage attrition is far more costly than drug candidate terminations occurring earlier in the development process. Among many other things, the PharmSource Lead Sheet provides coverage of products that have been terminated in Phase II & III. This enables clients to identify therapeutic categories that have been most at risk from attrition, providing insight into… read on
Follow the Money: Inotek Pharmaceuticals
INOTEK recently raised $40 million in an IPO. This early stage biotech company is pioneering glaucoma treatments. They plan to use the proceeds to advance development of their small molecule drugs currently in development, among other things. As yet, Inotek has no revenue, and will be dependent upon third-party service providers such as CROs, clinical data management organizations, clinical investigators and others to conduct clinical trials, perform data collection and analysis for product candidates. Inotek’s pipeline includes three… read on.
Sales Effectiveness: Manage Where it Counts
A large, cross-industry study conducted by Vantage Point Performance and the Sales Education Foundation identified over 300 metrics defined by company leaders as being important to effective sales management. Each metric was categorized into one of three buckets:
- Business Results (revenue, market share, etc.)
- Sales Objectives (winning customers, selling products, etc.)
- Sales Activities (number of sales calls, % of account plans completed, etc.)
The study’s sponsors set out to determine which of those metrics could be… read on
CMO Scorecard: Outsourcing of NDA Approvals and CMO Performance
Dose CMOs had more launches in 2014, thanks to a big jump in NDA approvals. But they aren’t making much headway in convincing bio/pharma companies to abandon in-house manufacture. For the most part the industry is dependent on the ebb and flow of the NDA tide. Find out what this means for your business.
Jim Miller and the PharmSource intelligence team have identified some other critical trends for the CMO industry:
- Global bio/pharma companies don’t outsource many NMEs, but when they do they have a few favorite CMOs.
- NMEs tend to get approved by FDA before being approved by EMA, which may have implications for European CMOs.
Bio/Pharmaceutical Outsourcing Report – Special DCAT Edition
This monthly report covers deals and happenings throughout the industry. It provides expert insight into the significance of industry trends and what they mean for your business.
Find out what’s happening in commercial and clinical dose manufacturing and packaging, API small and large molecule, captive capacity, regulatory developments and more.
Get your copy from the PharmSource team at DCAT. Or click here to download a complimentary copy.
PharmSource Lead Sheet
The PharmSource Lead Sheet is the industry’s definitive source for identifying targeted new business opportunities in bio/pharmaceutical companies around the world. Our dedicated research team knows how and where to find fresh, targeted leads, and we have the contact information you need to start the sales process.
Don’t be the last to learn about the latest business development opportunities. If you’re not already using the Lead Sheet, contact us today to schedule a complimentary test-drive.
See for yourself how this resource can be a vital tool for building your brand and growing your market share.
To request a test-drive today, contact Nathaniel Celentano at firstname.lastname@example.org / 1-703-383-4903, ext. 112 (ET USA).